柴芍六君子汤对原发性肝癌患者化疗期间疗效及免疫功能的影响

Effect of Chaishao Liujunzi decoction on therapeutic effect and immune function of primary liver cancer during chemotherapy

目的:观察柴芍六君子汤用于原发性肝癌患者化疗的效果及随访情况。方法:选取106例原发性肝癌患者纳入研究,按抽签法分为观察组、对照组,各53例。对照组采用FOLFOX4方案化疗,观察组在化疗基础上服用柴芍六君子汤治疗。记录两组患者疗效及不良反应,比较两组患者中医证候积分、Th1/Th2细胞因子谱变化及治疗6个月后随访情况。结果:观察组客观反应率高于对照组,差异有统计学意义(P<0.05)。治疗后两组患者上腹胀满、倦怠短气、下肢浮肿、大便溏数的评分下降,且观察组低于对照组,差异有统计学意义(均P<0.05)。治疗后两组患者血清干扰素-γ(IFN-γ)、白细胞介素-2(IL-2)上升,白细胞介素-4(IL-4)、白细胞介素-10(IL-10)下降,且观察组改变程度高于对照组,差异有统计学意义(均P<0.05)。两组不良反应总发生率比较,差异无统计学意义(P>0.05)。随访6个月,观察组生存率为92.45%,对照组生存率为83.12%,组间比较差异无统计学意义(P>0.05)。结论:柴芍六君子汤用于原发性肝癌化疗能减轻患者症状,提高免疫功能,且安全性较好。

Objective:To observe efficacy and follow-up of Chaishao Liujunzi decoction in patients with primary liver cancer during chemotherapy.Methods:106 patients with primary liver cancer were selected for study.Patients were divided into observation group and control group by drawing lots,with 53 cases in each group.The control group received chemotherapy with FOLFOX4 regimen,while the observation group treated with Chaishao Liujunzi decoction on the basis of chemotherapy.Record therapeutic effects and adverse reactions of the two groups,and traditional Chinese medicine syndrome scores,Th1/Th2 cytokine levels,and follow-up after 6 months of treatment between the two groups were compared.Results:The objective response rate of the observation group were higher than that in the control group,difference statistically significant(P<0.05).After treatment,the scores of upper abdominal swelling,fatigue and shortness of breath,lower limb edema and loose stools significantly decreased in both groups,and the observation group lower than the control group,difference statistically significant(all P<0.05).After treatment,serum level of IFN-γ,IL-2 in two groups significantly increased,while IL-4,IL-10 significantly decreased,degree of change in the observation group were higher than those in the control group(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Follow up for 6 months showed survival rate of 92.45%in the observation group and 83.12%in the control group.There was no significant difference between the two groups(P>0.05).Conclusion:Chaishao Liujunzi decoction has significant therapeutic effect on patients with primary liver cancer during chemotherapy,which can alleviate symptoms,improve immune function,and security was better.